Yang Li
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 15
- Immunology top 2%
- Immunotherapy and Immune Responses 18
- Immune cells in cancer 16
- Immune Cell Function and Interaction 15
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics 31
- Biochemistry top 2%
- Pollution top 2%
-
- Cancer Immunotherapy and Biomarkers 20
-
- Nanoparticles: synthesis and applications 15
-
- Air Quality and Health Impacts 15
Yang Li
281 papers receiving 6.8k citations
Peers
Comparison fields: 5 of 179
- Biomaterials 648
- Immunology 1.0k
- Biomedical Engineering 1.7k
- Biochemistry 216
- Pollution 405
Countries citing papers authored by Yang Li
This map shows the geographic impact of Yang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Li more than expected).
Fields of papers citing papers by Yang Li
This network shows the impact of papers produced by Yang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Li. The network helps show where Yang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 26 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 48 | |
| 15 | 2021 | 33 | |
| 16 | 2018 | 100 | |
| 17 | 2017 | 16 | |
| 18 | 2014 | 5 | |
| 19 | 2014 | 3 | |
| 20 | 2012 | 49 |
About Yang Li
Yang Li is a scholar working on Immunology, Biomaterials, Biomedical Engineering, Health, Toxicology and Mutagenesis and Oncology, having authored 302 papers that have together received 6.9k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (31 papers), Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (18 papers), Immune cells in cancer (16 papers), Nanoparticles: synthesis and applications (15 papers), Immune Cell Function and Interaction (15 papers), Air Quality and Health Impacts (15 papers) and Nanoparticle-Based Drug Delivery (15 papers). The work is most often cited by research in Biomaterials (648 citations), Immunology (1.0k citations), Biomedical Engineering (1.7k citations), Biochemistry (216 citations) and Pollution (405 citations). Yang Li has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Diana Boraschi, Chunying Chen, Ying Liu, Junchao Duan, Nancy A. Monteiro‐Riviere, Zhong‐Li Liu, Longmin Wu, Bo Zhou, Yan-Zhong Chang and Taotao Wei. Their work appears in journals such as Frontiers in Immunology, Scientific Reports, Sensors and Actuators B Chemical, Nanomedicine and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.